20 years of Cure Parkinson's
We’re here for the cure! This year marks 20 years since Cure Parkinson’s was founded by four people living with Parkinson’s who felt that nobody was taking a cure seriously enough and that there was an urgent need for a focused approach to curative research...
Learn more
Payroll Giving Month 2023: how you can help your employees support the causes they care about
Cure Parkinson’s is pleased to announce that a large-scale phase 3 clinical trial of ambroxol, to determine whether the drug can slow the progression of Parkinson’s.
Cure Parkinson’s announces new chair of trustees
We are delighted to announce Peter Berners-Price as chair of our board of trustees.
£1,000 Challenge
Raise £1,000 for game-changing Parkinson’s research. The £1,000 challenge is as simple as it sounds! The best bit? It’s entirely up to you how you do it and there’s no time limit. Organise one big event, or take your time and reach this fantastic amount...
Biotech Inhibikase develops new drug for Parkinson’s
Researchers have published laboratory data demonstrating the neuroprotective effects of a new potential drug for Parkinson’s called IkT-148009.
European Software Industry helps fund research to cure Parkinson’s
Cure Parkinson’s is delighted to announce that it has been chosen as the official charity partner to Boardwave supporting Parkinson’s research.